Demo Sign up Log In

Celldex Therapeutics Inc (CLDX)

R&D Expenses

$67.55M

Quarterly · Period ending: Jun 30, 2026 · USD

CLDX R&D Expenses

Latest reported$67.55Mperiod endingJun 30, 2026

Latest reported$67.55Mperiod endingJun 30, 2026

CLDX Quarterly R&D Expenses ($0.00 → $67.55M)

Quarterly R&D Expenses

High-resolution chart · PNG

CLDX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc R&D Expenses — Quarterly (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	5,440,500
Mar 31, 2001	3,976,700
Dec 31, 2000	3,701,500
Sep 30, 2000	3,292,700
Jun 30, 2000	1,962,700
Mar 31, 2000	1,817,300
Dec 31, 1999	2,171,800
Sep 30, 1999	1,900,000
Jun 30, 1999	1,900,000
Mar 31, 1999	1,900,000
Dec 31, 1998	1,600,000
Sep 30, 1998	1,800,000
Jun 30, 1998	1,200,000
Mar 31, 1998	1,100,000
Dec 31, 1997	1,200,000
Sep 30, 1997	1,300,000
Jun 30, 1997	1,500,000
Mar 31, 1997	1,300,000
Dec 31, 1996	1,600,000
Sep 30, 1996	1,500,000
Jun 30, 1996	1,400,000
Mar 31, 1996	1,500,000
Dec 31, 1995	2,000,000
Sep 30, 1995	2,000,000
Jun 30, 1995	2,000,000
Mar 31, 1995	2,000,000
Dec 31, 1994	1,400,000
Sep 30, 1994	2,200,000
Jun 30, 1994	2,500,000
Mar 31, 1994	2,600,000
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Oct 31, 1992	0
Jul 31, 1992	0
Apr 30, 1992	0
Jan 31, 1992	0
Oct 31, 1991	0
Jul 31, 1991	0
Apr 30, 1991	0
Jan 31, 1991	0
Oct 31, 1990	0
Jul 31, 1990	0
Apr 30, 1990	0
Jan 31, 1990	0
Oct 31, 1989	0
Jul 31, 1989	0
Apr 30, 1989	0
Jan 31, 1989	0
Oct 31, 1988	0
Jul 31, 1988	0
Apr 30, 1988	0
Jan 31, 1988	0
Oct 31, 1987	0
Jul 31, 1987	0
Apr 30, 1987	0
Jan 31, 1987	0
Oct 31, 1986	0
Jul 31, 1986	0
Apr 30, 1986	0
Jan 31, 1986	0
Oct 31, 1985	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.